Coxarthrosis and periarticular pathology of the hip: clinical manifestations, diagnosis, approaches to therapy
https://doi.org/10.14412/1996-7012-2012-709
Abstract
Osteoarthrosis (OA) is the most common joint disease affecting both men and men. There is primary and secondary OA. Up to now, the causes of primary OA remain unclear. Secondary OA is associated with the presence of joint injury in the history, with congenital anomalies of the structure, metabolic diseases, endocrinopathies, etc. It is particularly difficult to interpret coxarthrosis if there are signs offemoroacetabular impingement. Periarticular pathology plays an important role in the origin of the hip pain syndrome that accompanies or mimics the symptoms of coxarthrosis. The main goals of OA therapy are to slow down the progression of cartilage degeneration and to maintain joint function as much as possible. Combination drugs containing chondroitin sulfate and glucosamine hydrochloride are widely used to treat OA today.
References
1. <div><p>Ревматология. Клинические рекомендации. Под ред. Е.Л. Насонова. М.: ГЭОТАР-Медиа, 2008; 288 с.</p><p>Osteoarthritic Disorders. Kuettner K.E., Goldberg V.M. (ed.). Rosemont, IL: American Academy of Orthopedic Surgeons, 1995.</p><p>Seedhom B.B. Conditioning of cartilage during normal activities is an important factor in the development of osteoarthritis. Rheumatology 2006; 45(2): 146—9.</p><p>Beck M., Leunig M., Clarke E. et al. Hip morphology influences the pattern of damage to the acetabular cartilage: femoroacetabular impingement as a cause of early osteoarthritis of the hip. J Bone Joint Surg Br 2005; 87: 1012—18.</p><p>Ganz R., Leunig M., Leunig-Ganz K. et al. The etiology of osteoarthritis of the hip. An Integrated Mechanical Concept. Clin Orthop Relat Res 2008; 466(2): 264—72.</p><p>Goldriring M.B. The role of the chondrocyte in osteoarthritis. Arthr Rheum 2000; 43(9): 1916—26.</p><p>Mastbergen S.C., Bijlsma J.W., Lafeber F.P. Synthesis and release of human cartilage matrix proteoglycans are differently regulated by nitric oxide and prostaglandin-E2. Ann Rheum Dis 2008; 67(1): 52—8.</p><p>Цветкова Е.С. Современная терапия остеоартроза — патогенетическое обоснование. Тер. арх. 2004; 5: 77—9.</p><p>Алексеева Л.И., Зайцева Е.М. Субхондральная кость при остеоартрозе: новые возможности терапии. РМЖ 2004; 12: 1133—6.</p><p>Henrotin Y.E. Bone-derived mediators and cartilage degradation. Ann Rheum Dis 2006; 65: 10.</p><p>Westacott C.I., Webb G.R., Elson C.J. Cells from osteoarthritic bone produse enzymes which degrade cartilage. Trans Orthop Res Soc 1998; 23: 919.</p><p>Li B., Marshall D., Roe M. et al. The electron microscope appearance of the subchondral bone plate in the human femoral head in osteoarthritis and osteoporosis. J Anat 1999; 195: 101—10.</p><p>Sowers M.R., Zobel D., Weissfeld L. et al. Progression of osteoarthritis of the hand and metacarpal bone loss. A twenty-year follow up of incident cases. Arthr Rheum 1991; 34: 36—42.</p><p>Altman R., Alarcon G., Appelrouth D. et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthr Rheum 1991; 34: 505—14.</p><p>Watts R., Climil G., Hall F. Oxford Desk Reference: Rheumatology. Oxford: University Press, 2009,603.</p><p>Arthritis and Allied Conditioins: A Textbook of Rheumatology, 13th ed. W.J. Koopman (ed.). Williams & Wilkins, 1997; 2374.</p><p>Klippel J.H. Primer on the Rheumatic Diseases,12th ed. In: L.J. Grofford, J.H. Stone, C.M. Weyand. Atlanta, Georgia, 2001.</p><p>Рекомендации Международного научно-исследовательского общества по проблемам остеоартрита.</p></div><br />
Review
For citations:
Shostak NA. Coxarthrosis and periarticular pathology of the hip: clinical manifestations, diagnosis, approaches to therapy. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2012;6(1):15-21. (In Russ.) https://doi.org/10.14412/1996-7012-2012-709
Views:
1642
Email this article 